Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO) [Phase 3]
Phase 3 trial comparing duvelisib to ofatumumab in relapsed/refractory CLL/SLL has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL [Phase 1, Phase 2]
A Phase 1b/2 study investigates duvelisib (IPI-145) plus FCR in previously untreated, younger patients with chronic lymphocytic leukemia; th…
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years [Phase 2]
Phase 2 trial evaluating FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in previously untreated patients with chronic lympho…
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Reduced Intensity Double Umbilical Cord Blood Transplantation [Phase 2]
Phase 2 results for reduced-intensity double umbilical cord blood transplantation were completed and results posted in 2018. The study evalu…
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies [Phase 2]
Phase 2 trial of Deoxycoformycin (pentostatin) in lymphoid malignancies completed, studying Peripheral T-cell Lymphoma and Cutaneous T-cell …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia [Phase 3]
Phase 3 trial evaluating obinutuzumab alone or with chemotherapy for chronic lymphocytic leukemia has completed, with results posted in 2018…
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial evaluating bone marrow transplantation in patients with Chronic Lymphocytic Leukemia.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase II study evaluating lenalidomide (Revlimid) combined with rituximab in relapsed or refractory chronic lymphocytic leukemia has complet…
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
Clinical trial update for rituximab in chronic lymphocytic leukemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial of lenalidomide in relapsed or refractory chronic lymphocytic leukemia completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 3]
Phase 3 trial comparing venetoclax plus rituximab vs bendamustine plus rituximab in relapsed/refractory chronic lymphocytic leukemia; result…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [Phase 2]
Phase 2 trial evaluating cyclosporine with T-cell add-back in blood cell transplant settings for hematologic cancers, including chronic lymp…
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating rituximab plus sargramostim (GM-CSF) in patients with chronic lymphocytic leukemia has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial investigating ofatumumab, pentostatin, and cyclophosphamide for untreated chronic lymphocytic leukemia or small lymphocytic ly…
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL) [Phase 3]
Phase 3 trial evaluating maintenance rituximab versus no treatment in progressive chronic lymphocytic leukemia; results posted after complet…
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: CLLR3: Bendamustine + GA101 (BG) in Relapsed or Refractory CLL Followed by GA101 Maintenance for Responding Patients [Phase 2]
Phase 2 trial of bendamustine plus GA101 (obinutuzumab) in relapsed/refractory chronic lymphocytic leukemia with GA101 maintenance for respo…
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab [Phase 2]
Phase 2 trial update on optimized donor selection with nonmyeloablative bone marrow transplant using post-transplant cyclophosphamide and ri…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
This Clinical Trial Update describes a study collecting and storing malignant and related samples from young cancer patients; the trial stat…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) [Phase 2]
A Phase 2 trial evaluating eltrombopag for immune thrombocytopenia occurring in patients with chronic lymphoproliferative disorders has comp…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 clinical trial update of the BTK inhibitor Ibrutinib (PCI-32765) in special cases of chronic lymphocytic leukemia and small lymphocy…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [Phase 1]
Phase 1 clinical trial evaluating donor T-helper 2 (Th2) cell therapy to prevent graft-versus-host disease after bone marrow transplantation…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Improving Blood Stem Cell Collection and Transplant Procedures [Phase 1, Phase 2]
Phase 1/2 clinical trial update focused on improving blood stem cell collection and transplant procedures, completed with results reported b…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation [Phase 1]
Phase 1 trial update reporting completion of a study evaluating ultra-low-dose interleukin-2 as graft-versus-host disease prophylaxis in hap…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation [Phase 1]
This Phase 1 trial evaluates adoptive cell therapy for B-cell cancers in patients after stem cell transplantation, focusing on chronic lymph…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating a triple regimen of devimistat (CPI-613), bendamustine hydrochloride, and rituximab in relapsed or refractory B-cel…